615 related articles for article (PubMed ID: 27567846)
1. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
2. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
4. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
5. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
[TBL] [Abstract][Full Text] [Related]
6. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
7. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS
J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
9. Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.
Carbonell F; Zijdenbos AP; Bedell BJ;
J Alzheimers Dis; 2020; 73(2):543-557. PubMed ID: 31796668
[TBL] [Abstract][Full Text] [Related]
10. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
11. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
[TBL] [Abstract][Full Text] [Related]
12. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
[TBL] [Abstract][Full Text] [Related]
14. APOE effects on regional tau in preclinical Alzheimer's disease.
Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
[TBL] [Abstract][Full Text] [Related]
15. APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.
Liu Y; Yu JT; Wang HF; Han PR; Tan CC; Wang C; Meng XF; Risacher SL; Saykin AJ; Tan L
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):127-34. PubMed ID: 24838911
[TBL] [Abstract][Full Text] [Related]
16. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
17. β-Amyloid is associated with aberrant metabolic connectivity in subjects with mild cognitive impairment.
Carbonell F; Charil A; Zijdenbos AP; Evans AC; Bedell BJ
J Cereb Blood Flow Metab; 2014 Jul; 34(7):1169-79. PubMed ID: 24736891
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
Wang J; Wang M; Ren S; Huang L; He K; Li J; Hua F; Guan Y; Guo Q; Huang Q; Xie F
J Alzheimers Dis; 2023; 94(2):763-775. PubMed ID: 37334590
[TBL] [Abstract][Full Text] [Related]
19. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
[TBL] [Abstract][Full Text] [Related]
20. The effect of β-amyloid positivity on cerebral metabolism in cognitively normal seniors.
Bozoki AC; Zdanukiewicz M; Zhu DC;
Alzheimers Dement; 2016 Dec; 12(12):1250-1258. PubMed ID: 27445158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]